ISL
14.10.2019 12:51:06 CEST | Business Wire | Press release
The second and final day of the International Swimming League’s first tour of Europe proved to be the most exciting of the young season thus far, as a sold out crowd at the Piscina Felipe Scandone in Naples, Italy, were treated to a pair of tight club battles that came down to the final event.
The passion of the European fans was very evident to those competing, giving them a boost late in the match.
“It's really cool how great this has been unfolding,” said Cali Condor’s Caeleb Dressel , who was named MVP with a match-high 57.5 points. “Again this is my first meet, but everyone loved Indy. And this is, I think, even a step up from that because it's in Europe this time. I think the fans are a little bit crazier, a little bit better, a little bit more into it.”
"This is a whole other level of things. I mean, the crowd for one, but the lights, the DJ, the walkout, it makes it seem like an event. Not just something that you get to watch, but you feel like you're a part of it.”
“The energy on deck, I can still feel it right now as I'm sitting here,” said DC Trident captain Cody Miller in a post-match media scrum. “It was awesome, it was a lot of fun, and I think that there's just more greatness to come. It was so, so fun.”
Another thing that stood out to Miller was the noise, which was exaggerated due to the way the building was constructed.
"I think probably cause the pool is mostly made of concrete...the noise! I have not been to many facilities where the noise is that awesome, it makes it fun. It makes it fun for us, it makes it fun for people that are watching,” said Miller enthusiastically.
“I think that makes a big difference with the energy levels,” said Energy Standard male captain Chad Le Clos on how the crowd impacted the match. “Doing back-to-back races - 50 fly, 200 fly, 100 freestyle - getting back up (on the blocks) was very special, and a big thank you to the crowd. Altogether it was a great show.”
DC Trident coach Cyndi Gallagher had a similar perspective as the athletes, really enjoying the vibe that the match produced.
“I think this is super fun, exciting,” Gallagher said in an interview during one of the breaks. “I love the crowd, I love that they're getting the crowd into it, the music, the DJ, our energy is great. We are all in.”
Sarah Sjostrom , a Swede who is one of the sport’s biggest stars in Europe, always loves swimming in front of an Italian crowd.
"They love the Italian swimmers, but they do love the other swimmers as well,” said the 2016 Olympic gold medalist. “The other swimming stars, even if you're from Sweden. I always love racing in Italy. So it's a lot of fun to have very good supporters here in the stands.”
The match was tightly contested for first place between Energy Standard, who won last weekend in Indianapolis, and the Cali Condors, who received a significant boost with Dressel making his debut.
Dressel went out and won the final event, the men’s skins, which are worth triple the points. However, his Energy Standard counterparts Florent Manaudou and Ben Proud placed second and third to secure another win for their club.
"It hurts. I mean, I'd much rather have a team title than MVP, 100 percent of the time,” said Dressel, who won a total of four individual events over the two days. “It definitely stings, but it's cool, there's already started (to be) rivalries (developing) and stuff. Of course, friendly rivalries. I respect everyone on that team, but I would've liked to win the meet. And it was so close which is what makes it hurt a little bit more.”
The 23-year-old is confident the Condors will continue to improve and have a good chance of winning it all at the league grand final in Vegas in December.
“I could've been better throughout the meet and scored more points, we all could've been, everyone across the board. We're on a good progression for now, from Indy to here, so we'll find some more room to be better, and then hopefully by Vegas we'll have it figured out.”
Miller’s Trident club was locked in a close race with the hometown Aqua Centurions, going back and forth throughout the match in the race for third.
“We have two teams, my team (DC Trident) and the Aqua Centurions, vying for just a few points here and there. It feels like it's an NBA game. It feels like a basketball game,” he said. “We were a ways behind the two front-running teams, but were still in a tight race with another team, so, it's exciting.”
“There's a rivalry. It's a good rivalry, It's been fun.”
About the ISL: The International Swimming League is a global professional swimming competition launching in 2019 with teams in both Europe (Italy-based Aqua Centurions, France-based Energy Standard, Hungary-based Iron, and London Roar) and the United States (Cali Condors, DC Trident, LA Current, NY Breakers). The inaugural season will include matches in Indianapolis IN, Naples ITA, Lewisville TX, Budapest HUN, College Park MD, London GBR, and the championship finale at the 12,000-seat Mandalay Bay Events Center in Las Vegas, NV. The ISL aims to create groundbreaking projects, in both form and content, exploring the full potential of competitive swimming while securing sustainable commercial growth in the sport.
Key Dates:
5-6 October 2019 – IU Natatorium, Indianapolis, USA
12-13 October 2019 – Aquatic Swimming Complex, Naples, Italy
19-20 October 2019 – The LISD Westside Aquatic Center, Lewisville, Texas, USA
26-27 October 2019 – Duna Area, Budapest, Hungary
16-17 November 2019 – Natatorium at the Eppley Recreation Center, Maryland, USA
23-24 November 2019 – London Aquatic Centre, Great Britain
20-21 December 2019 – Mandalay Bay Resort and Casino, Las Vegas, USA
ISL SOCIAL:
Keep up with all the latest ISL news by following @iswimleague on Instagram and Twitter and @internationalswimmingleague on Facebook.
Visit https://isl.global
For latest images, video and stories go to
http://apmultimedianewsroom.com/multimedia-newsroom/partners/international-swimming-league
View source version on businesswire.com: https://www.businesswire.com/news/home/20191014005313/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
